"At ASH, we had numberous presentations showing that combinations using novel agents are allowing us to achieve very high complete remission rates and is changing the treatment options for newly-diagnosed patients."
Dr. Sundar Jagannath
This video provided by the International Myeloma Foundation (http://www.myeloma.org)
Link to this comment:
All Comments (0)